Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine receptor excess and mouse madness.

Solomon H Snyder1

  • 1Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Neuron
|February 16, 2006
PubMed
Summary

Schizophrenia's dopamine hypothesis is challenged by new mouse models. Overexpressing dopamine D2 receptors in the striatum caused cognitive deficits, suggesting striatal receptors impact cortical dopamine function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifaceted roles for persulfide species in redox chemical biology.

Nature chemical biology·2026
Same author

Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Biliverdin reductase A is a major determinant of protective NRF2 signaling.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signaling.

bioRxiv : the preprint server for biology·2025
Same author

Mammalian D-Cysteine controls insulin secretion in the pancreas.

Molecular metabolism·2024
Same author

Inositol Pyrophosphates as Versatile Metabolic Messengers.

Annual review of biochemistry·2024

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • The dopamine hypothesis of schizophrenia posits that excessive dopamine D2 receptor activity underlies the disorder.
  • Antipsychotic medications primarily function by antagonizing dopamine D2 receptors, supporting this hypothesis.
  • Dopamine-releasing agents are known to exacerbate schizophrenic symptoms.

Discussion:

  • This study introduces a novel transgenic mouse model with selective striatal overexpression of dopamine D2 receptors.
  • These mice exhibit specific cognitive impairments, mirroring frontal cortical dysfunction observed in schizophrenia.
  • The findings suggest a potential link between striatal dopamine receptor function and prefrontal cortex dopamine regulation.

Key Insights:

  • Striatal dopamine D2 receptor overexpression can induce cognitive deficits characteristic of schizophrenia.
  • Altered striatal dopamine receptor activity influences dopamine signaling in the prefrontal cortex.
  • This provides a new perspective on the neurobiological underpinnings of schizophrenia and cognitive dysfunction.

Outlook:

  • Further research can explore the precise mechanisms by which striatal dopamine receptors modulate cortical function.
  • This model may facilitate the development of more targeted and effective antipsychotic therapies.
  • Investigating the role of D2 receptors in different brain regions could reveal novel therapeutic strategies for cognitive deficits in schizophrenia.

Related Experiment Videos